Medicare Coverage for Alzheimer’s and Dementia in Florida 2026

By the Florida Plan Finder Team · Licensed Florida Health Insurance Producer · NPN #21249133 · Last Updated: May 2026

Alzheimer's disease affects more than 580,000 Floridians, and that number is projected to grow significantly as the state's population ages. Florida families dealing with Alzheimer's or other forms of dementia face a complex web of medical care, financial decisions, and care planning. Understanding what Medicare covers — and where its limitations lie — is essential to building a realistic care plan and protecting family finances.

What Medicare Covers for Alzheimer's and Dementia

Medicare covers a meaningful range of Alzheimer's-related medical services, particularly in the diagnostic and acute care phases:

• Cognitive assessment and care planning: The Annual Wellness Visit (AWV) includes a cognitive health assessment at no cost. If cognitive concerns arise during the AWV, Medicare covers a separate, dedicated cognitive assessment visit and a comprehensive care planning session — these are covered at $0 with no copay as preventive services.
• Diagnostic workup: MRI and CT brain imaging covered under Part B (20% coinsurance after deductible). Amyloid PET scans — which can identify amyloid plaques consistent with Alzheimer's pathology — are covered under CED (Coverage with Evidence Development) for patients who are candidates for anti-amyloid therapy. A standard diagnostic PET scan for dementia evaluation may also be covered in certain clinical circumstances.
• Specialist consultations: Visits to neurologists, geriatric psychiatrists, and geriatric medicine specialists are covered under Part B with standard 20% coinsurance. Florida has strong academic neurology programs at the University of Florida, University of Miami, and USF Health.
• Inpatient hospital stays: Covered under Part A with standard benefit period cost-sharing — for hospitalizations related to behavioral symptoms, falls, infections, or other acute conditions associated with dementia.
• Skilled nursing facility (SNF) care: Covered under Part A following a qualifying 3-day hospital stay — covers up to 100 days per benefit period for skilled rehabilitation or skilled nursing needs related to a dementia-associated medical event.

New Alzheimer's Drugs — Leqembi and Kisunla

Two anti-amyloid antibody treatments represent a genuine breakthrough in Alzheimer's disease treatment — the first drugs shown to slow cognitive decline rather than merely manage symptoms:

• Lecanemab (Leqembi): FDA approved in January 2023. An intravenous infusion administered every two weeks. Shown to slow cognitive decline by approximately 27% in clinical trials. Indicated for early Alzheimer's with confirmed amyloid pathology.
• Donanemab (Kisunla): FDA approved in July 2024. Monthly IV infusion. Shown to slow decline by approximately 35% in patients with low-to-medium tau burden. Like Leqembi, indicated for early-stage disease.

CMS initially restricted Medicare coverage to clinical trial participants, but expanded coverage in 2024 under a Coverage with Evidence Development (CED) framework. Under CED, Medicare covers these drugs when administered at enrolled facilities that participate in approved data collection registries — meaning the patient's outcomes are tracked as part of ongoing real-world evidence collection.

These drugs carry a risk of amyloid-related imaging abnormalities (ARIA) — brain swelling or microbleeds — that require MRI monitoring during treatment. Patients must have amyloid confirmed by PET scan or cerebrospinal fluid analysis before starting. The eligibility criteria are specific to early-stage disease — mild cognitive impairment or mild dementia due to Alzheimer's pathology.

Part D Coverage for Alzheimer's Medications

Medicare Part D covers the medications used to manage Alzheimer's symptoms. The most commonly prescribed drugs are:

• Cholinesterase inhibitors: Donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne) — generic versions are widely available and typically covered at Tier 1 (preferred generic) or Tier 2 on most Part D formularies. Monthly cost-sharing is usually $0–$10 for generics.
• Memantine (Namenda): NMDA receptor antagonist used for moderate-to-severe Alzheimer's — also widely available as a generic and covered at Tier 1 or Tier 2 on most formularies.
• Combination therapy (Namzaric): Brand-name donepezil/memantine combination capsule — covered by Part D but at a higher tier; generic alternatives are available and less expensive.

When comparing Part D plans, confirm the formulary tier and prior authorization requirements for your specific medications. The Medicare Plan Finder at medicare.gov allows you to enter your drug list and compare total annual costs across available plans in your Florida county.

The Memory Care Facility Gap — Medicare's Largest Limitation

The most significant financial challenge for Alzheimer's families is what Medicare does not cover: the cost of living in a memory care facility. Memory care units are specialized residential facilities — typically within assisted living communities — designed for people with dementia who need 24-hour supervision, secure environments, and specialized programming.

In Florida, memory care facility costs in 2026 typically range from $4,000 to $8,000 per month depending on location, amenity level, and care intensity. Facilities in Sarasota, Naples, and Palm Beach areas often run at the higher end of this range. Over a multi-year illness trajectory, total costs can easily exceed $200,000 to $500,000.

Medicare will not pay any of this cost. Memory care is classified as custodial residential care — not skilled medical care — and Medicare explicitly excludes custodial care from coverage. A brief Medicare SNF stay (up to 100 days) may follow an acute hospitalization, but ongoing residential memory care is not covered.

Medicaid and PACE Programs in Florida

For Floridians who cannot afford private-pay memory care, two public programs provide critical options:

Florida Medicaid

Florida Medicaid covers nursing home care and some home and community-based services for qualifying low-income seniors. To qualify for Florida Medicaid long-term care, an individual typically must have assets below approximately $2,000 (excluding the primary home, one vehicle, and certain exempt items) and income below the Medicaid income standard. A community spouse may retain additional assets under spousal protection rules.

Asset spend-down — the process of reducing assets to qualify — is a significant planning challenge given the high cost of memory care and FL property values. Elder law attorneys and Certified Senior Advisors can assist with Medicaid planning, though planning must occur well before care is needed to avoid look-back period complications.

PACE — Program of All-Inclusive Care for the Elderly

PACE is a fully integrated care model for adults 55 and older who are nursing-home eligible but wish to remain in the community. PACE organizations receive combined Medicare and Medicaid funding and provide comprehensive services — medical care, pharmacy, physical therapy, day program services, transportation, and caregiver support — all through a single coordinated system. For dementia patients who are dual-eligible (enrolled in both Medicare and Medicaid), PACE can be an exceptionally comprehensive and cost-effective option. PACE programs operate in Tampa, Jacksonville, South Florida, and other Florida markets.

Caregiver Resources in Florida

Family caregivers of Alzheimer's patients face significant emotional, physical, and logistical burdens. Florida has several strong support resources:

• Alzheimer's Association 24/7 Helpline: 800-272-3900 — available around the clock for caregivers with questions, crisis support, and local chapter connections. Florida has active chapters in Southeast Florida, Central and North Florida, Greater Tampa Bay, and Northwest Florida.
• Elder Care Locator: 800-677-1116 — a national service connecting Florida families with local Area Agencies on Aging, respite care, caregiver support groups, and meal programs.
• SHINE Counselors: 800-963-5337 — Florida's free Medicare counseling program helps families navigate Medicare and Medicaid benefits, including understanding what's covered for dementia care.
• Florida Department of Elder Affairs (DOEA): Administers the Community Care for the Elderly (CCE) program, which funds in-home services for frail elders including those with dementia.

Advance Planning — Before Cognitive Decline Progresses

Legal and financial planning must happen while the person with Alzheimer's still has legal capacity to execute documents. This is one of the most time-sensitive aspects of an Alzheimer's diagnosis. Key documents under Florida law:

• Durable Power of Attorney: Designates a trusted person to manage financial and legal decisions. Must be executed while the principal has capacity.
• Designation of Health Care Surrogate: Florida's version of a healthcare proxy — designates who can make medical decisions when the patient cannot. Critical for healthcare decisions at all care stages.
• POLST Form (Physician Orders for Life-Sustaining Treatment): A medical order signed by a physician that travels with the patient and directs emergency responders and healthcare providers on specific interventions — CPR preferences, hospitalization wishes, artificial nutrition. More immediately enforceable than a living will in Florida emergency settings.
• Living Will: Expresses general healthcare wishes — can be used alongside a POLST form.
• Medicaid planning: If private funds are limited, consult an elder law attorney about legal asset protection strategies well in advance of needing Medicaid-funded care.

Frequently Asked Questions